Tissue expansion

Sientra Receives Innovative Technology Contract from Vizient for AlloX2® Tissue Expander

Retrieved on: 
Wednesday, May 5, 2021
Medical specialties, Plastic surgery, Tissue expansion, Breast cancer, Periprosthetic, Clinical medicine, Medicine

The AlloX2 is the only tissue expander on the market with an integral drain providing direct access to the periprosthetic space where fluid can accumulate.

Key Points: 
  • The AlloX2 is the only tissue expander on the market with an integral drain providing direct access to the periprosthetic space where fluid can accumulate.
  • The AlloX2 was innovatively designed to mitigate risks associated with breast expansion and ultimately reduce reoperation rates.\n\xe2\x80\x9cWe are delighted to receive an Innovative Technology contract, as it highlights the importance of the transformative technology in our AlloX2 product,\xe2\x80\x9d said Ron Menezes, President and Chief Executive Officer of Sientra.
  • With this contract award, Sientra\xe2\x80\x99s AlloX2 is now on contract with all major GPOs in the nation and available to all reconstruction hospitals in the US.
  • Through its Innovative Technology Program , Vizient works with member-led councils and task forces to review potentially innovative products.

Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual Property for Mino-Wrap

Retrieved on: 
Wednesday, August 26, 2020
Clinical medicine, Medical specialties, Medicine, Breast surgery, RTT, Plastic surgery, Tissue expansion, Breast reconstruction, Surgical oncology, Breast cancer, Mastectomy, Cancer

Through this license agreement, Citius is developing Mino-Wrap, which is a novel approach to reducing post-mastectomy infections associated with the use of a tissue expander ("TE").

Key Points: 
  • Through this license agreement, Citius is developing Mino-Wrap, which is a novel approach to reducing post-mastectomy infections associated with the use of a tissue expander ("TE").
  • The intellectual property expansion was granted to The Board of Regents of The University of Texas System on behalf of The University of Texas M. D. Anderson Cancer Center and enhances the design and use of Mino-Wrap.
  • "We are especially pleased that the claims for Mino-Wrap intellectual property are being expanded and broadened as we develop the optimal design and application."
  • A common breast reconstruction technique is tissue expansion, which involves expansion of the breast skin and muscle using a temporary tissue expander.

$603.8 Million Worldwide Breast Reconstruction Industry to 2025 - Featuring Allergan, Sientra & Sebbin Among Others

Retrieved on: 
Thursday, June 18, 2020
Medicine, Breast surgery, Medical specialties, Surgery, Prosthetics, Breast reconstruction, Breast implant, Breast cancer, Implant, Tissue expansion

The breast reconstruction market is expected to reach 603.8 million by 2025 from USD 430.8 million in 2020, at a CAGR of 7.0%.

Key Points: 
  • The breast reconstruction market is expected to reach 603.8 million by 2025 from USD 430.8 million in 2020, at a CAGR of 7.0%.
  • Growth in this industry is driven by the rising incidences of breast cancer, increasing awareness, and the availability of reimbursements.
  • The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix.
  • Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period.

Breast Reconstruction Market by Product, Procedure, Type and End-user - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Monday, June 15, 2020
Surgery, Health, Other Health, Breast surgery, Medicine, Medical specialties, Surgery, Prosthetics, Breast reconstruction, Plastic surgery, Breast implant, Tissue expansion, Breast cancer, Implant, Breast augmentation

0The "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • 0The "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The breast reconstruction market is expected to reach 603.8 million by 2025 from USD 430.8 million in 2020, at a CAGR of 7.0%.
  • The breast reconstruction market, by product, is categorized into breast implants, tissue expanders, and acellular dermal matrix.
  • Immediate procedures are expected to remain the fastest-growing segment of the global breast reconstruction market during the breast reconstruction period.

Establishment Labs’ Motiva Flora Tissue Expander Receives CE Mark

Retrieved on: 
Thursday, June 11, 2020
Medicine, Medical specialties, Surgery, Plastic surgery, Prosthetics, Motiva, Tissue expansion, Breast enlargement, Implant, Magnetic resonance imaging, Radio-frequency identification, Expander

NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on womens health, initially in the breast aesthetics and reconstruction market, today announcedit has received CE Mark for the Motiva Flora Tissue Expander.

Key Points: 
  • NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on womens health, initially in the breast aesthetics and reconstruction market, today announcedit has received CE Mark for the Motiva Flora Tissue Expander.
  • The Motiva Flora Tissue Expander, with its proprietary SmoothSilk surface, is the only such product with an integrated RFID port with no magnets, allowing for use of the expander safely alongside MRI scanning.
  • Already a leader in the European breast enhancement market with its portfolio of Motiva branded products, Establishment Labs intends to extend its presence into the reconstruction market with the introduction of its Flora tissue expander alongside Motiva Implants.
  • The Motiva Flora Tissue Expander is not available for sale or approved in the United States.

Breast Reconstruction Market Worth $603 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, June 4, 2020
Medicine, Breast surgery, Medical specialties, Surgery, Prosthetics, Plastic surgery, Breast implant, Breast reconstruction, Tissue expansion, Implant, Breast cancer, Breast augmentation

CHICAGO, June 4, 2020 /PRNewswire/ -- According to the new market research report "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025", published by MarketsandMarkets, the global Breast Reconstruction Market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025.

Key Points: 
  • CHICAGO, June 4, 2020 /PRNewswire/ -- According to the new market research report "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025", published by MarketsandMarkets, the global Breast Reconstruction Market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025.
  • The rising incidence of breast cancer and the availability of reimbursement for breast reconstruction are major driving factors for the market.
  • Breast implants accounted for the largest share of the breast reconstruction market, by product, in 2019.
  • Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix.

Breast Reconstruction Market Worth $603 Million by 2025 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, June 4, 2020
Medicine, Breast surgery, Medical specialties, Surgery, Prosthetics, Plastic surgery, Breast implant, Breast reconstruction, Tissue expansion, Implant, Breast cancer, Breast augmentation

CHICAGO, June 4, 2020 /PRNewswire/ -- According to the new market research report "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025", published by MarketsandMarkets, the global Breast Reconstruction Market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025.

Key Points: 
  • CHICAGO, June 4, 2020 /PRNewswire/ -- According to the new market research report "Breast Reconstruction Market by Product (Breast implant (Silicone, Saline), Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospital, Cosmetology Clinics) - Global Forecast to 2025", published by MarketsandMarkets, the global Breast Reconstruction Market size is projected to reach USD 603 million by 2025 from USD 430 million in 2020, at a CAGR of 7.0% from 2020 to 2025.
  • The rising incidence of breast cancer and the availability of reimbursement for breast reconstruction are major driving factors for the market.
  • Breast implants accounted for the largest share of the breast reconstruction market, by product, in 2019.
  • Based on the product, the breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix.

The Global Tissue Expander Market is expected to grow from USD 1,223.13 Million in 2018 to USD 1,857.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.14%

Retrieved on: 
Wednesday, April 15, 2020
Plastic surgery, Tissue expansion, Surgery

On the basis of End-User, the Global Tissue Expander Market is studied across Ambulatory Surgical Centers, Cosmetology Clinics, and Hospitals.

Key Points: 
  • On the basis of End-User, the Global Tissue Expander Market is studied across Ambulatory Surgical Centers, Cosmetology Clinics, and Hospitals.
  • What are the factors that affect the growth in the Global Tissue Expander Market over the forecast period?
  • Which are the best product areas to be invested in over the forecast period in the Global Tissue Expander Market?
  • What are the modes of entering the Global Tissue Expander Market?

First Patient Enrolled in AVITA Medical’s Pivotal Study Evaluating RECELL System for Soft Tissue Reconstruction

Retrieved on: 
Tuesday, March 3, 2020
Research, Hospitals, FDA, Clinical trials, Stem cells, Biotechnology, General Health, Pharmaceutical, Health, Science, Medical specialties, Medicine, Clinical medicine, Plastic surgery, Transplantation medicine, Avita Medical, Skin grafting, Graft, Surgery, Tissue expansion

We are pleased to have initiated this registration trial and to have enrolled the first patient in this study.

Key Points: 
  • We are pleased to have initiated this registration trial and to have enrolled the first patient in this study.
  • Skin grafting is the standard of care for full-thickness, soft tissue reconstruction, including post-trauma and post-surgical skin reconstruction.
  • We are eager to evaluate use of the RECELL System as a way to reduce the amount of donor skin required.
  • AVITA Medicals first U.S. product, the RECELL System, was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

Global Breast Reconstruction Market 2020-2024 | Evolving Opportunities With Allergan Plc and CEREPLAS | Technavio

Retrieved on: 
Monday, January 27, 2020
Surgery, Health, Oncology, Medicine, Breast surgery, Medical specialties, Surgery, Prosthetics, Plastic surgery, Breast implant, Cosmetic surgery, Tissue expansion, Breast reconstruction, Breast cancer, Breast augmentation

View the full release here: https://www.businesswire.com/news/home/20200127005353/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20200127005353/en/
    Technavio has announced its latest market research report titled global breast reconstruction market 2020-2024.
  • The rising incidence of breast cancer and strong research funding are factors anticipated to boost the growth of the market.
  • Request a free sample report
    Related Reports on Health Care include:
    Breast Implants Market Global Breast Implants Market by geography (Asia, Europe, North America, and ROW), product (silicone breast implants and saline breast implants), and application (breast cosmetic surgery and breast reconstruction surgery).
  • Breast Tissue Expander Market Global Breast Tissue Expander Market by product (saline-filled breast tissue expanders and air-filled breast tissue expanders) and geography (Asia, Europe, North America, and ROW).